Skip to main content

Table 1 Variables of interest taken from the Treatment Demand Indicator Database (2011–2014) and the InterMutualistic Agency Database (2008–2014)

From: Utilization of gabapentin by people in treatment for substance use disorders in Belgium (2011–2014): a cross-sectional study

Variables only available for subjects (Source: TDI)

 

 Treatment center

 

  Region where subject was treated

 

  Type of program

 

 Subject’s characteristics

 

  Nationality

 

  Educational attainment

 

  Professional situation

 

 Treatment episode for substance use disorders

 

  Date of inclusion (treatment starting date)

 

  Previous treatment episodes (yes/no)

 

  Source of referral

 

  Primary substance

 

  Patterns of use for primary substance

 

  Injecting status

 

Variables available for subjects and comparators (Source: IMA)

 

 Patient characteristics

 

  Age

 

  Sex

 

  Place of residence

 

 Medication purchases

 

  Day, month and year of purchase of gabapentin

 

  Inpatient or outpatient delivery

 

  Product specificities (Defined Daily Doses (DDDs), Quantities Per Package (QPP), Quantities Per Unit (QPU))